World Economic Forum: women’s health gets only 20% of R&D funding. We must seize this $1 trillion opportunity
A new radar developed with the Gates Foundation and Wellcome Leap reveals that fewer than 3% of clinical trials are women-specific.
Original Source
Read the full article at Fortune →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.